UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
318.50
+7.94 (2.56%)
At close: Jun 12, 2025, 4:00 PM
315.60
-2.90 (-0.91%)
Pre-market: Jun 13, 2025, 7:05 AM EDT
UnitedHealth Group Stock Forecast
Stock Price Forecast
According to 24 professional analysts, the 12-month price target for UnitedHealth Group stock ranges from a low of $270 to a high of $700. The average analyst price target of $447.33 forecasts a 40.45% increase in the stock price over the next year.
Price Target: $447.33 (+40.45%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for UnitedHealth Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 6 | 6 |
| Buy | 12 | 12 | 12 | 14 | 15 | 14 |
| Hold | 2 | 2 | 2 | 2 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 21 | 23 | 25 | 25 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy → Hold Downgrades $356 → $312 | Buy → Hold | Downgrades | $356 → $312 | -2.04% | Jun 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $552 → $353 | Buy | Maintains | $552 → $353 | +10.83% | Jun 3, 2025 |
| Barclays | Barclays | Buy Maintains $362 → $350 | Buy | Maintains | $362 → $350 | +9.89% | Jun 2, 2025 |
| Keybanc | Keybanc | Buy Maintains $450 → $400 | Buy | Maintains | $450 → $400 | +25.59% | Jun 2, 2025 |
| HSBC | HSBC | Hold → Sell Downgrades $490 → $270 | Hold → Sell | Downgrades | $490 → $270 | -15.23% | May 21, 2025 |
Financial Forecast
Revenue This Year
454.91B
from 400.28B
Increased by 13.65%
Revenue Next Year
485.56B
from 454.91B
Increased by 6.74%
EPS This Year
24.31
from 15.51
Increased by 56.74%
EPS Next Year
27.93
from 24.31
Increased by 14.91%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 481.2B | 521.9B | 558.0B | ||
| Avg | 454.9B | 485.6B | 520.3B | ||
| Low | 435.0B | 445.0B | 482.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.2% | 14.7% | 14.9% | ||
| Avg | 13.6% | 6.7% | 7.2% | ||
| Low | 8.7% | -2.2% | -0.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.76 | 33.20 | 38.71 | ||
| Avg | 24.31 | 27.93 | 31.66 | ||
| Low | 21.56 | 24.01 | 27.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 79.0% | 36.6% | 38.6% | ||
| Avg | 56.7% | 14.9% | 13.3% | ||
| Low | 39.0% | -1.2% | -2.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.